Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...
In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot.
NEW YORK (WABC) -- More evidence is being released about the safety of the Pfizer and Moderna vaccines during pregnancy, as two new studies found the shots do not increase the risk of miscarriage for ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects ...
Nov 18 (Reuters) - COVID-19 vaccines from Pfizer Inc (PFE.N), opens new tab and Moderna Inc (MRNA.O), opens new tab could be ready for U.S. authorization and distribution within weeks, setting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback